ARTICLE
25 September 2024

Loper Bright Calls For Early Advocacy

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
The perspective by Joseph Impicciche (Modern Healthcare September 2024) of Ascension hits home for me as an advocate for healthcare of more than 25 years.
United States Food, Drugs, Healthcare, Life Sciences

The perspective by Joseph Impicciche (Modern Healthcare September 2024) of Ascension hits home for me as an advocate for healthcare of more than 25 years. In those two and half decades, I have actively worked on legislation and rulemaking for healthcare entities, professionals and patients. It was not uncommon for specifics to be worked out through the rulemaking process. Whether one might believe this process is right or wrong, the reality is Loper Bright now requires Congress to have a clearer intent and more specifics in their legislative language. This will require an early voice in the process to not only ensure your agenda is advanced but of equal importance that legislative language does not negatively impact you. As the saying goes--If you are not at the table, you might be on the menu.

For the healthcare community, Loper Bright offers a clear lesson: The healthcare industry's advocacy and lobbying work must equip Congress with clear and unambiguous language. When proposing policy solutions to protect and strengthen America's healthcare system and support patients, clarity is paramount. (Modern Healthcare September 2024; Voices by Joseph Impicciche, CEO of Ascension)

www.modernhealthcare.com/...

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More